Poor and low-prognosis responders: Bologna and POSEIDON
On this page you will learn
- How the Bologna criteria define a poor (low) responder
- How the POSEIDON groups re-frame the problem as "low prognosis"
- What the evidence says about higher stimulation and add-ons in this group
- How to counsel honestly, mention donor options under the Act, and agree when to stop
Principles only. Medicines and doses are decided by the treating specialist for each patient; this page explains principles only.
Words matter: "low", not "poor"
The 2025 ESHRE update suggests the words low, normal and high response, because "poor responder" can wound a woman who already feels she is failing. Its definition of low response is still the Bologna one. In the clinic, speak of a low response or a low egg count; in the file, record which definition you used.
Source: Apr 2026, ESHRE, Human Reproduction 41(4):498-514 - ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025
Bologna 2011
An ESHRE working group agreed a simple rule in Bologna. A woman is a poor responder when at least two of three features are present:
- Advanced age, or another risk factor for a low response
- A previous low response with a conventional stimulation
- An abnormal ovarian reserve test, such as a low AFC or AMH
Two low responses after maximal stimulation are enough by themselves. A woman of advanced age with an abnormal reserve test who has not yet had a cycle is called an expected poor responder.
Source: 2011, Ferraretti et al. (ESHRE working group), Human Reproduction 26(7):1616-1624 - ESHRE consensus on the definition of 'poor response' to ovarian stimulation for IVF: the Bologna criteria
Bologna made trials comparable, but it lumped together very different women: a 28-year-old with a surprising low response and a 43-year-old with almost no follicles.
POSEIDON 2016: the low-prognosis concept
The POSEIDON group asked a more useful question: what is this woman's chance of having at least one chromosomally normal embryo to transfer? Age drives the quality of eggs; reserve drives their number. So the group made four boxes:
- Group 1: younger woman, good reserve markers, but an unexpected low or below-expected egg count
- Group 2: older woman, good reserve markers, unexpected low or below-expected count
- Group 3: younger woman with low reserve markers
- Group 4: older woman with low reserve markers
Source: 2016, POSEIDON Group (Alviggi et al.), Fertility and Sterility 105(6):1452-1453 - A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept
The groups help planning. Groups 1 and 2 may have had a stimulation that did not suit them, so the next plan is reviewed. Groups 3 and 4 have fewer follicles to work with; in group 4, age also lowers the share of normal embryos, so counselling must be most careful there.
What changes the outcome, and what does not
Here the evidence is sobering. ESHRE 2025 does not recommend pushing gonadotropins above the conventional upper level in predicted low responders, nor routine delayed-start or modified natural cycles over conventional stimulation. For women with very low reserve it allows the clinician to choose a modified natural cycle. It does not recommend growth hormone, testosterone, DHEA, sildenafil or aspirin as stimulation adjuncts.
Source: Apr 2026, ESHRE, Human Reproduction 41(4):498-514 - ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025
Two newer ideas have a place with limits. Double stimulation in one cycle can be used to collect more oocytes or embryos when no fresh transfer is planned; it does not change what each egg can do. A low response alone is not a reason to cancel: the specialist counsels the woman and decides with her whether to continue.
Source: Apr 2026, ESHRE, Human Reproduction 41(4):498-514 - ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025
Many paid extras sold to this group lack support. The ESHRE add-ons recommendations list the same hormonal adjuncts as not recommended, and double stimulation as not for routine use (page 65).
Source: 2023, ESHRE Add-ons Working Group, Human Reproduction 38(11):2062-2104 - Good practice recommendations on add-ons in reproductive medicine
Honest counselling and when to stop
A low-prognosis couple deserves the truth in plain words: their own chance, what each option adds, and its cost. The ART Act requires clinics to counsel on the implications and chances of treatment, its risks and cost, and to help the couple reach an informed decision.
Source: 18 Dec 2021, Government of India (Act No. 42 of 2021) - The Assisted Reproductive Technology (Regulation) Act, 2021 (section 21(c))
- Agree a stopping point before the first cycle, not after the third failure
- Discuss donor oocytes as an option when it fits; donor gametes come only from a registered bank (page 68)
- Offer emotional support; a low response is grief for many women
- Never sell hope through unproven add-ons
At the clinic
On Day OB-5 the faculty takes you through two anonymised low-response files. You place each woman in a POSEIDON group, list what was changed for the next cycle and why, and hear how the counselling was worded. Ultrasound scans are watched only: no trainee holds the probe on a patient (PCPNDT Act).
The lab side
With few oocytes, every one counts. The embryologist will report how many were mature (page 51); share that number in the counselling, because it, more than the follicle count, shapes the next plan.
Common mistakes
- Calling a woman a poor responder after one badly planned cycle
- Raising gonadotropins again and again in a woman with very low reserve
- Adding growth hormone or DHEA "just in case"
- Never discussing when to stop
Key points
- Bologna defines low response; POSEIDON adds age and reserve to define low prognosis
- Higher stimulation and hormonal adjuncts are not recommended routinely
- Double stimulation can collect more oocytes when no fresh transfer is planned, but is not routine
- Counsel honestly, mention donor options, agree when to stop
Check yourself
Answer in your head first, then tap a question to see a short answer. Full model answers are in the faculty guidebook.
1. State the Bologna definition of a poor responder.
At least two of: advanced age or another risk factor, a previous poor response, and an abnormal ovarian reserve test.
2. How does POSEIDON differ from Bologna?
It sorts low-prognosis women into four groups by age, ovarian reserve and any past response, aiming at a realistic plan.
3. Name three adjuncts ESHRE does not recommend for low responders.
Growth hormone, testosterone and DHEA (also sildenafil and aspirin).
4. Is a low response alone a reason to cancel the cycle?
No. ESHRE says a low response alone is not a reason to cancel; counsel her and decide individually.
5. What must honest counselling of a low-prognosis couple include?
Their real chances, the limits of add-ons, donor options under the ART Act, and when to stop.
6. From page 44: what is the aim of stimulation in IVF?
A safe number of mature oocytes for the woman, not the largest possible number.
Training note. Training content for registered medical practitioners. Trainees observe all patient care; they do not treat patients during the programme.
Questions on this page
What is a POSEIDON group?
One of four low-prognosis groups based on age, ovarian reserve markers and any previous response.
Does growth hormone help low responders?
ESHRE does not recommend growth hormone or other hormonal adjuncts routinely.
The Genesis Doctors' Textbook is teaching text for registered medical practitioners on the doctor programmes of the Genesis ART Training Academy. It is not treatment advice and gives no medicine doses; trainees observe all patient care, ultrasound scans are watched only (PCPNDT Act), and bench skills are practised under supervision. Page numbers never change.
